Titre:
  • Prognostic factors associated with increased survival in patients with pulmonary arterial hypertension treated with subcutaneous treprostinil in randomized, placebo-controlled trials.
Auteur:Benza, Raymond L.; Gomberg-Maitland, Mardi; Naeije, Robert; Arneson, Carl; Lang, Irene M.
Informations sur la publication:The Journal of heart and lung transplantation
Statut de publication:Publié, 2011-04
Sujet CREF:Physiologie générale
Mots-clés:6MWD
medical therapy
prostacyclin
survival
Note générale:JOURNAL ARTICLE
SCOPUS: re.j
Langue:Autre
Identificateurs:urn:issn:1053-2498
info:doi/10.1016/j.healun.2011.03.011
info:pii/S1053-2498(11)00873-4
info:scp/80051471867
info:pmid/21531577